Thrive Capital Management (Pennsylvania)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.9M | Buy |
6,807
+6,016
| +761% | +$1.68M | 0.6% | 73 |
|
2025
Q1 | $247K | Buy |
+791
| New | +$247K | 0.15% | 105 |
|
2024
Q4 | – | Sell |
-878
| Closed | -$283K | – | 100 |
|
2024
Q3 | $283K | Sell |
878
-235
| -21% | -$75.8K | 0.13% | 157 |
|
2024
Q2 | $348K | Sell |
1,113
-3,421
| -75% | -$1.07M | 0.16% | 149 |
|
2024
Q1 | $1.29M | Buy |
4,534
+3,333
| +278% | +$948K | 0.69% | 24 |
|
2023
Q4 | $346K | Sell |
1,201
-808
| -40% | -$233K | 0.19% | 88 |
|
2023
Q3 | $540K | Buy |
2,009
+91
| +5% | +$24.5K | 0.3% | 54 |
|
2023
Q2 | $426K | Buy |
1,918
+686
| +56% | +$152K | 0.24% | 70 |
|
2023
Q1 | $298K | Buy |
1,232
+388
| +46% | +$93.7K | 0.19% | 90 |
|
2022
Q4 | $222K | Sell |
844
-835
| -50% | -$219K | 0.15% | 108 |
|
2022
Q3 | $378K | Buy |
+1,679
| New | +$378K | 0.26% | 70 |
|